BioSpace News Archive

Agendia, Inc., a world leader in precision oncology, today announced the publication of study results for BluePrint®, its 80-gene proprietary molecular subtyping test, in Nature Breast Cancer

This year’s Clinical Trial Supply West Coast Conference will see leading biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) showcasing its specialist clinical trials expertise in relation to scheduled drugs.

SEngine Precision Medicine, an oncology startup accelerating cancer drug discovery through its proprietary diagnostic tool known as the PARIS Test®, today welcomed Dr. Jonathan Baell to the SEngine Precision Medicine Scientific Advisory Board.

Millendo Therapeutics, Inc. announced that on April 23, 2019, the Compensation Committee of the Board of Directors approved, effective as of April 23, 2019, the grant of inducement stock options to purchase a total of 65,000 shares of the Company’s common stock to three newly-appointed employees of the Company.

Vital, the AI-powered software increasing productivity and improving patient health in hospital emergency rooms, today announces a $5.2 million Seed round Led by First Round Capital and DFJ.

The Canadian Snowbird Association announced Wednesday their opposition to the Ontario government’s proposal to terminate OHIP’s Out-of-Country Travellers Program.

Medicure Inc., a pharmaceutical company, will release financial results for the year ended December 31, 2018 after markets close on Monday, April 29, 2019.

New project will improve access to vaccination and increase vaccine coverage

Marler Clark, the food safety law firm, is investigating the Salmonella outbreak linked to Caito Foods LLC of Indianapolis, Indiana.

he SanBio Group announced that Advanced Therapy Medicinal Product (ATMP) classification has been granted for SB623 for the treatment of patients with motor deficits arising from Acquired Brain Injury, including traumatic brain injury, ischemic stroke and haemorrhagic stroke.